Immunofluorescence staining results showed that a larger amount of Gal-3 was expressed in drug-resistant colon cancer tissue than in normal colon tissue (Fig. 1A, B; Additional file 1: Fig. S1). This evidence concerns the gene LGALS3 and colonic neoplasm.